Development and Validation of a HPLC–MS/MS Method for Quantification of Andrographolide in Rat Plasma by Using Lithium Adduct Detection
Biomedical Chromatography · 2026-09 · 40 (9)
DOI: 10.1002/bmc.70569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 22.07.2026. Verfasst von Lei Mingdao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jiangxi Maternal and Child Health Hospital, Nanchang, China. Hauptthemen laut MEDLINE: Diterpenes, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Lithium. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Program from Jiangxi Provincial Health Commission, Program from Jiangxi Provincial Administration of Tradition, National Natural Science Foundation of China.
Abstract (Originalsprache)
In this study, a simple high‐performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) method has been developed for quantification of andrographolide in rat plasma using andrographolide‐lithium adduct as the precursor ion for the first time. The addition of lithium carbonate into the mobile phase could increase the mass response of andrographolide by approximately 100‐fold. The analytes were retained and separated on a C18 column and analyzed using a triple quadrupole mass spectrometer equipped with an ESI source. Andrographolide exhibited excellent retention on the C18 column under optimized chromatographic conditions. A simple protein precipitation pretreatment resulted in high extraction recovery (approximately 100%) and negligible matrix effects. The method was linear over the concentration range of 2.00–1606.00 ng/mL. Both precision and accuracy were within acceptable limits. This simple HPLC–MS/MS method has been validated and successfully applied to support pharmacokinetic studies of andrographolide in Sprague–Dawley rats. The present study also provided a strategy for improving the mass response of drugs with low ionization efficiency, especially compounds from plants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
- West China Second Hospital, Sichuan University, Chengdu, China.
- The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
- Division of Pharmaceutics, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
ORCID-Profile: Huang Haijin, Sun Yongbing
Förderung
- Program from Jiangxi Provincial Health Commission
- Program from Jiangxi Provincial Administration of Tradition
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Advanced Innovation Talents of Science and Technology in Jiangxi Province
Zitieren
APA
Mingdao, L., Haijin, H., Xiaoliang, L., Guoshuang, P., & Yongbing, S. (2026). Development and Validation of a HPLC–MS/MS Method for Quantification of Andrographolide in Rat Plasma by Using Lithium Adduct Detection. Biomedical Chromatography, 40(9). https://doi.org/10.1002/bmc.70569
Vancouver
Mingdao L, Haijin H, Xiaoliang L, Guoshuang P, Yongbing S. Development and Validation of a HPLC–MS/MS Method for Quantification of Andrographolide in Rat Plasma by Using Lithium Adduct Detection. Biomedical Chromatography. 2026;40(9). doi:10.1002/bmc.70569
BibTeX
@article{Mingdao2026,
author = {Mingdao, Lei and Haijin, Huang and Xiaoliang, Luo and Guoshuang, Peng and Yongbing, Sun},
title = {Development and Validation of a HPLC–MS/MS Method for Quantification of Andrographolide in Rat Plasma by Using Lithium Adduct Detection},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {9},
doi = {10.1002/bmc.70569}
}
EUVIMED